Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$33.51 0.16 (0.48%) as of 4:30 Thu 9/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 2.78(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $34.32
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  749
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 89,268 111,047 121,047 489,528
Total Sell Value $2,735,873 $3,195,462 $3,439,061 $13,197,122
Total People Sold 4 5 5 8
Total Sell Transactions 15 20 21 44
End Date 2024-06-27 2024-03-26 2023-09-26 2022-09-26

   
Records found: 582
  Page 9 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-06-04 4 AS $33.28 $314,515 D/D (9,081) 51,887     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-06-04 4 OE $5.98 $102,135 D/D 8,156 60,968     -
   Holstein Jens Director   –       •      –    2021-06-03 4 B $35.19 $70,389 D/D 2,000 2,000 2.39     -
   Anderson Bonnie H Executive Chairwoman   •       •      –    2021-06-02 4 D $36.07 $82,528 D/D (2,288) 189,725     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-06-02 4 D $36.07 $32,896 D/D (912) 52,812     -
   Stapley Marc Chief Executive Officer   •       –      –    2021-06-01 4 A $0.00 $0 D/D 46,807 46,807     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-05-17 4 OE $5.61 $78,905 D/D 14,065 192,013     -
   Alley Beverly Jane VP, Corporate Controller   •       –      –    2021-05-17 4 A $0.00 $0 D/D 5,500 13,000     -
   Eastham Karin Director   –       •      –    2021-05-03 4 AS $48.01 $213,700 I/I (4,427) 8,800     -
   Bhanji Muna Director   –       •      –    2021-03-19 4 A $0.00 $0 D/D 11,541 11,541     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-03-04 4 AS $47.11 $2,567,271 D/D (52,015) 53,724     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-03-04 4 OE $5.98 $582,299 D/D 30,970 105,739     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-03-02 4 D $62.15 $372,589 D/D (5,995) 74,769     -
   Ho Mark Principal Accounting Officer   –       –      –    2021-03-02 4 D $62.15 $30,454 D/D (490) 71,728     -
   Kennedy Keith COO / CFO   •       –      –    2021-03-02 4 D $62.15 $359,413 D/D (5,783) 116,858     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-03-02 4 D $62.15 $392,788 D/D (6,320) 177,948     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-02-26 4 A $0.00 $0 D/D 20,000 184,268     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-02-26 4 A $0.00 $0 D/D 12,500 80,764     -
   Kennedy Keith COO / CFO   •       –      –    2021-02-26 4 A $0.00 $0 D/D 15,000 122,641     -
   Erlinger Iii James H EVP, General Counsel   –       –      –    2021-02-26 4 A $0.00 $0 D/D 7,500 7,500     -
   Eastham Karin Director   –       •      –    2021-02-25 4 AS $60.03 $379,359 D/D (6,250) 0     -
   Eastham Karin Director   –       •      –    2021-02-25 4 OE $4.00 $25,000 D/D 6,250 6,250     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2021-02-24 4 D $62.30 $2,460,102 D/D (39,488) 164,268     -
   Kennedy Keith COO / CFO   •       –      –    2021-02-24 4 D $62.30 $688,166 D/D (11,046) 107,641     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       –      –    2021-02-24 4 D $62.30 $625,990 D/D (10,048) 68,264     -
  582 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us